James Dudko assesses the potential impact of the Detroit Lions' top draft pick.
It may not be the catchiest of names, but AstraZeneca drug MEDI4736 was revealed on Wednesday night as a "new great white hope" in the fight against cancer as it took centre stage in the British company's battle against Pfizer's planned £63bn takeover.
Describing PepsiCo as having a "culture of sycophants," a prominent activist investor vowed that reform would come to the food and beverage giant-and signaled that part of the change would have to be to its management mentality.
India-born former Goldman Sachs director Rajat Gupta has sought a stay on a US court order to start serving a two-year sentence from June 17 on insider trading charges, contending that his bail conditions should be continued till his motion to rehear his case is decided upon.
Banking group HSBC has attempted to head off investor criticism over a new pay plan, capping any share bonus for its Chairman Douglas Flint this year at £1m ($1.68m) and saying it would be a one off.
Flappy Bird creator Dong Nguyen told CNBC the app is returning later this year and the game will include multi-player capabilities and be less addictive.
Here is some excellent advice from an old hand to the directors of AstraZeneca should Pfizer, as expected, get serious about bidding and increase its current £48-a-share offer: don't be swayed by the views of investment bankers chasing success fees; don't judge bid premiums based on a two- to three-year view; and remember you have responsibilities beyond price.
Barcelona and Real Madrid are reportedly ready to axe players to ensure they sign Arturo Vidal from Juventus.
First, the facts.
Christopher Bailey, the fashion designer and new chief executive of Burberry, has been handed a golden hello in shares worth up to £7.6m and an annual pay package worth up to £8.1m a year, including a £440,000 cash allowance to cover clothing and other items.